Impulsivity and craving in subjects with opioid use disorder on methadone maintenance treatment. 2021

Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
Department of Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Methadone maintenance treatment (MMT) is effective in decreasing opioid use or facilitating abstinence. Previous studies using small opioid use disorder samples suggest that cognitive impairments including impulsivity and executive functions may partially improve on MMT, but a range of deficits may persist. However, systematic assessments with larger samples are needed to confirm the profile of cognitive functions on MMT. We assessed four types of impulsivity (delay discounting, reflection impulsivity, risk taking and motoric impulsivity), executive functioning (spatial working memory, paired associative learning and strategic planning) and drug cue-induced craving in a relatively large population (115 MMT patients, 115 healthy controls). The relationships between impulsivity, drug cue-induced craving and addiction-related variables were also assessed. Delay discounting, as well as drug cue-induced craving was increased in patients, while motoric impulsivity was lower than in controls. Paired associative learning was additionally impaired, which was explained by increased depression and anxiety levels in patients. Within the MMT group, the delay discounting and drug-cue induced craving scores were positively correlated with self-reported urgency, but unrelated to methadone dosage, duration on methadone, withdrawal symptoms, or presence of nicotine dependence. Our findings highlight increased delay discounting and cue-induced craving in MMT patients suggesting a potential role for trait effects in delay discounting. Although previous smaller studies have shown impaired executive function, in our large sample size on chronic MMT we only observed impaired associative learning related to depressive and anxiety symptoms highlighting a role for managing comorbid symptoms to further optimize cognitive function.

UI MeSH Term Description Entries
D007175 Impulsive Behavior An act performed without delay, reflection, voluntary direction or obvious control in response to a stimulus. Impulsivity,Behavior, Impulsive,Behaviors, Impulsive,Impulsive Behaviors,Impulsivities
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
April 2022, Biomedical journal,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
May 2024, Journal of psychiatric research,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
April 2024, Journal of hypertension,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
February 2015, American family physician,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
October 2021, NeoReviews,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
January 2023, Journal of addictive diseases,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
November 2020, Journal of pharmacy & bioallied sciences,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
August 2023, Journal of clinical and experimental neuropsychology,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
October 2019, BJPsych open,
Jun Li, and Kathrin Weidacker, and Alekhya Mandali, and Yingying Zhang, and Seb Whiteford, and Qihuan Ren, and Zhirong Zhou, and Huijing Zhou, and Haifeng Jiang, and Jiang Du, and Chencheng Zhang, and Bomin Sun, and Valerie Voon
February 2020, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology,
Copied contents to your clipboard!